v3.26.1
SCHEDULE OF ALLOCATION OF FAIR VALUE IN PRIVATE PLACEMENT (Details) - USD ($)
 3 Months Ended
Apr. 01, 2026
Mar. 31, 2026
Mar. 31, 2025
Jan. 23, 2026
 [1]
Subsidiary, Sale of Stock [Line Items]        
Allocation of Proceeds Common Stock   $ 145,701  
Share price   $ 0.0499    
Allocation of Proceeds Warrants   $ 95,339  
Allocation per Share/Warrant   $ 0.12    
Private Placement [Member]        
Subsidiary, Sale of Stock [Line Items]        
Fair value of common stock   $ 283,381    
% of Total Fair Value, Common stock   60.45%    
Allocation of Proceeds Common Stock   $ 145,701    
Share price   $ 0.0309   $ 0.031
Fair value of warrants   $ 185,430    
% of Total Fair Value, Warrants   39.55%    
Allocation of Proceeds Warrants   $ 95,339    
Allocation per Share/Warrant   $ 0.0218    
Standalone fair value   $ 468,811    
% of Total Fair Value   100.00%    
Allocation of Proceeds   $ 241,040    
Private Placement [Member] | Subsequent Event [Member]        
Subsidiary, Sale of Stock [Line Items]        
Fair value of common stock $ 56,864      
% of Total Fair Value, Common stock 61.76%      
Allocation of Proceeds Common Stock $ 45,453      
Share price $ 0.0316      
Fair value of warrants $ 35,213      
% of Total Fair Value, Warrants 38.24%      
Allocation of Proceeds Warrants $ 28,147      
Allocation per Share/Warrant $ 0.0211      
Standalone fair value $ 92,077      
% of Total Fair Value 100.00%      
Allocation of Proceeds $ 73,600      
[1] The Company claims an exemption from the registration requirements of the Securities Act for the private placement of these securities pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act.